Position in AZN
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$686,693,218
New position
Shares Held
3,481,864
first reported quarter
Ownership
0.225%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 41.65001849584016.ToString("F0")%
Shared 0.ToString("F0")%
None 58.34998150415984.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Pictet Asset Management Holding SA holds $3,378,373,394 across 13 Drug Manufacturers - General names. AZN ranks #2 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
943,976 | $868,240,805 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
3,481,864 | $686,693,218 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
2,574,822 | $358,852,942 | |
| 4 | JNJ |
Johnson & Johnson
|
1,460,529 | $357,011,708 | |
| 5 | AMGN |
Amgen Inc
|
830,595 | $292,244,850 | |
| 6 | ABBV |
AbbVie Inc.
|
1,173,729 | $255,274,320 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,486,425 | $178,802,063 | |
| 8 | BIIB |
Biogen Inc.
|
913,328 | $167,440,422 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $686,693,218 | 3,481,864 | Shares | Sole | 2026-04-22 | |
| No filing history on record for this holder in this stock. | ||||||